KRSNAA563.45

Krsnaa Diagnostics Limited

· Pharma & Health
₹ CrorePeersSURAKSHAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,828 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt159.8203.5534.3534.3
Net Debt157.4199.7504.1504.1
Total Debt/Equity0.200.230.550.55
Net Debt/Equity0.190.230.510.51
Total Debt/EBITDA1.111.072.522.52
Net Debt/EBITDA1.091.052.382.31
Interest Coverage (EBIT/Interest)4.234.133.533.53
Total Debt/Total Capital %16.4818.7435.2835.28
As Filed — company-reported covenants
Debt/Equity (as filed)0.53
Debt Service Coverage (as filed)2.81
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.